跳至主要内容
临床试验/NCT01214265
NCT01214265已完成不适用

A Pilot Clinical Study to Evaluate the Initial Feasibility of Neuromodulation Therapy in Treating Patients With Overactive Bladder Via Magnetic Stimulation of the Posterior Tibial Nerve

EMKinetics, Inc2 个研究点 分布在 1 个国家目标入组 8 人开始时间: 2009年10月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
8
试验地点
2
主要终点
Global Response Assessment

研究概览

简要总结

To evaluate the safety and feasibility of non-invasive magnetic stimulation of the posterior tibial nerve using the EMKinetics LoFIT Pulse System for treating patients with documented overactive bladder.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Women >18 years of age
  • A score of > 4 on the OAB-q short form for urgency (question 1)
  • Average urinary frequency > 10 times in one 24 hour day based on a 3-day voiding diary
  • Self-reported bladder symptoms present > 3 months
  • Self-reported failed conservative care (e.g., dietary restriction, fluid restriction, bladder training, behavioral modification, pelvic muscle training, biofeedback, etc.) or use of antimuscarinics.
  • Off all anti-muscarinics for at least 2 weeks prior to enrollment
  • Capable of giving informed consent
  • Ambulatory and able to use a toilet independently, without difficulty
  • Capable and willing to follow all study-related procedures

排除标准

  • The patient is pregnant or intends to become pregnant during the course of the study. (Patients becoming pregnant during the course of the study will immediately be terminated from the study.)
  • The patient has an active urinary tract infection.
  • Neurogenic bladder
  • Botox use in bladder or pelvic floor muscles in the past year
  • Pacemakers or implantable defibrillators
  • Primary complaint of stress urinary incontinence
  • Current vaginal infection
  • Current use of InterStim
  • Current use of Bion
  • Current use of TENS in the pelvic region, back or leg
  • Previously been treated with PTNS
  • Use of investigational drug/device therapy within the past 4 weeks
  • Participating or have participated within the past 4 weeks in any clinical investigation involving or impacting gynecologic, urinary or renal function
  • Deemed unsuitable for enrollment in study by the investigators based on subjects' history or physical examination
  • The patient has metal implant from surgery or a metallic foreign body in either leg below (distal to) the knee (or permanent metallic tattoo <30cm from left ankle).
  • The patient has chronic constipation (less than two (2) bowel movements per week)
  • The patient has history of gastric or urinary retention
  • The patient has uncontrolled diabetes
  • Subjects with nerve damage, injury or surgery that would impact either tibial nerve or pelvic floor function
  • The patient is unable or unwilling to sign informed consent
  • The patient is currently on pharmacologic treatment that could affect bladder function
  • Known Cystocele >/= to Grade 3 that has not been reduced by treatment (surgery or pessary)

结局指标

主要结局

Global Response Assessment

时间窗: After 12 weeks of therapy

Improved score on the Global Response Assessment (GRA) scale after 12 weeks of therapy. A score of 2 (moderately improved) or 3 (markedly improved) constitutes a responder on the 7 point scale

次要结局

  • Urinary Frequency(After 12 weeks of therapy)
  • Urinary Incontinence(After 12 weeks of therapy)
  • Overactive Bladder Symptoms (OAB-q SF)(After 12 weeks of therapy)

研究者

申办方类型
Industry

研究点 (2)

Loading locations...

相似试验

A Clinical Study for Magnetic Stimulation of the... | 临床试验